Stryker Director Ronda E. Stryker 7,000 Shares (SYK)
Stryker (NYSE:SYK) Director Ronda E. Stryker 7,000 shares of the company’s stock in a transaction dated Thursday, July 10th. Following the completion of the , the director now directly owns 174,605 shares in the company, valued at approximately $14,521,898. The was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link.
Several analysts have recently commented on the stock. Analysts at Zacks reiterated a “neutral” rating on shares of Stryker in a research note on Thursday. They now have a $88.00 price target on the stock. Separately, analysts at Cantor Fitzgerald raised their price target on shares of Stryker from $78.00 to $84.00 in a research note on Tuesday, July 1st. Finally, analysts at Argus upgraded shares of Stryker from a “hold” rating to a “buy” rating in a research note on Wednesday, June 11th. They now have a $102.00 price target on the stock. Eight analysts have rated the stock with a hold rating and eight have given a buy rating to the stock. Stryker currently has an average rating of “Buy” and a consensus target price of $83.22.
Shares of Stryker (NYSE:SYK) traded up 0.41% during mid-day trading on Friday, hitting $84.02. The stock had a trading volume of 562,736 shares. Stryker has a 52 week low of $66.44 and a 52 week high of $86.93. The stock’s 50-day moving average is $84.47 and its 200-day moving average is $80.65. The company has a market cap of $31.851 billion and a P/E ratio of 41.45.
Stryker (NYSE:SYK) last posted its quarterly earnings results on Wednesday, April 23rd. The company reported $1.06 EPS for the quarter, missing the Thomson Reuters consensus estimate of $1.09 by $0.03. The company had revenue of $2.31 billion for the quarter, compared to the consensus estimate of $2.33 billion. During the same quarter in the prior year, the company posted $1.03 earnings per share. The company’s quarterly revenue was up 5.3% on a year-over-year basis. Analysts expect that Stryker will post $4.80 EPS for the current fiscal year.
Stryker Corporation (NYSE:SYK) is a medical technology company.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.